| scholarly article | Q13442814 |
| P2093 | author name string | D Piomelli | |
| E di Tomaso | |||
| H Cadas | |||
| P2860 | cites work | Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh | Q48962059 |
| Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. | Q48963650 | ||
| Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. | Q52060269 | ||
| Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. | Q54001516 | ||
| Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes | Q59068519 | ||
| Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. Mechanism-based discrimination between calcium-dependent and -independent phospholipases A2 | Q70139295 | ||
| Stimulated production and natural occurrence of 1,2-diarachidonoylglycerophosphocholine in human neutrophils | Q70347932 | ||
| The effect of transient ischemia on fatty acid and lipid metabolism in the gerbil brain | Q70763906 | ||
| On the biosynthesis and metabolism of N-acylethanolamine phospholipids in infarcted dog heart | Q70820441 | ||
| Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities | Q70929217 | ||
| Strategy of glycerolipid separation and quantitation by complementary analytical techniques. Plenary lecture | Q71231181 | ||
| Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain | Q71583888 | ||
| N-Acylation of dog heart ethanolamine phospholipids by transacylase activity | Q71660413 | ||
| Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process | Q71693466 | ||
| Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide | Q71743278 | ||
| Tumor lipids: Metabolic relationships derived from structural analyses of acyl, alkyl, and alk-1-enyl moieties of neutral glycerides and phosphoglycerides | Q72393705 | ||
| The effect of long-chain N-acylethanolamines on some membrane-associated functions of neuroblastoma C1300 N18 cells | Q72551970 | ||
| Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization | Q72631582 | ||
| Cannabinoid receptor localization in brain | Q24558751 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist | Q28262546 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 | ||
| Properties of rat liver N-acylethanolamine amidohydrolase | Q34200418 | ||
| Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide | Q34309026 | ||
| The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons | Q34380089 | ||
| Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes | Q35592076 | ||
| Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction | Q36482564 | ||
| Leukotrienes in the rat central nervous system | Q37571714 | ||
| N-acylated glycerophospholipids and their derivatives | Q37793330 | ||
| Health aspects of cannabis | Q39238279 | ||
| Cannabinoid pharmacology | Q39741984 | ||
| Regional distribution of substance P in the spinal cord and nerve roots of the cat and the effect of dorsal root section | Q39923482 | ||
| A method for concurrent measurement of picomole quantities of acetylcholine, choline, dopamine, norepinephrine, serotonin, 5-hydroxytryptophan, 5-hydroxyindoleacetic acid, tryptophan, tyrosine, glycine, aspartate, glutamate, alanine, and gamma-amino | Q40323950 | ||
| Pharmacology of cannabinoid receptors | Q40437020 | ||
| The N-acylation-phosphodiesterase pathway and cell signalling | Q41016506 | ||
| Distribution of vasoactive intestinal polypeptide in the rat and mouse brain | Q41160101 | ||
| Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. | Q41529589 | ||
| α-Methyl-p-tyrosine inhibits the production of free arachidonic acid and diacylglycerols in brain after a single electroconvulsive shock | Q41701096 | ||
| Metabolism of unique diarachidonoyl and linoleoylarachidonoyl species of ethanolamine and choline phosphoglycerides in rat testes | Q42225655 | ||
| Localization of cannabinoid receptor mRNA in rat brain | Q42510202 | ||
| Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. | Q42553964 | ||
| N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain | Q44269681 | ||
| Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. | Q44596651 | ||
| The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice | Q45087565 | ||
| The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor | Q48121956 | ||
| Isolation and identification of lipoxygenase products from the rat central nervous system | Q48171621 | ||
| Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase | Q48251232 | ||
| Primary culture of identified neurons from the visual cortex of postnatal rats. | Q48292813 | ||
| Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent | Q48332786 | ||
| Cannabinoids modulate potassium current in cultured hippocampal neurons. | Q48388103 | ||
| Effects of ischemia on free fatty acids and diacylglycerols in developing rat brain. | Q48537308 | ||
| Identification of two molecular species of rat brain phosphatidylcholine that rapidly incorporate and turn over arachidonic acid in vivo. | Q48909794 | ||
| Membrane localization of N-acylphosphatidylethanolamine in central neurons: studies with exogenous phospholipases. | Q48924656 | ||
| Brain cannabinoids in chocolate. | Q48940587 | ||
| Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. | Q48942589 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoids | Q422936 |
| P304 | page(s) | 1226-1242 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain | |
| P478 | volume | 17 |
| Q34472174 | 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. |
| Q34098975 | 2-Arachidonoylglycerol and the cannabinoid receptors |
| Q28275316 | 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+-dependent and -independent mechanisms |
| Q37187919 | A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines |
| Q44853701 | A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission |
| Q26999343 | A fatty gut feeling |
| Q34069221 | A liquid chromatography-tandem mass spectrometry method for measurement of N-modified phosphatidylethanolamines |
| Q64212085 | A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain |
| Q91106132 | A protective role for N-acylphosphatidylethanolamine phospholipase D in 6-OHDA-induced neurodegeneration |
| Q35035844 | A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation |
| Q28248073 | A second endogenous cannabinoid that modulates long-term potentiation |
| Q34205553 | A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development |
| Q36617529 | ABHD4 regulates multiple classes of N-acyl phospholipids in the mammalian central nervous system |
| Q44361480 | Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure |
| Q39766503 | Activity-based probes that target functional subclasses of phospholipases in proteomes |
| Q42825579 | Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids-Cannabinoids and Acute Stress Modulate GABA Release |
| Q33560137 | Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals |
| Q47958621 | Alternative pathways of anandamide biosynthesis in rat testes |
| Q35159081 | An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease. |
| Q28284331 | An analgesia circuit activated by cannabinoids |
| Q34100956 | An anorexic lipid mediator regulated by feeding. |
| Q36977733 | An overview on the biochemistry of the cannabinoid system |
| Q36727266 | Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain |
| Q35678770 | Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. |
| Q33953174 | Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. |
| Q34387949 | Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism |
| Q59054886 | Bidirectional control of airway responsiveness by endogenous cannabinoids |
| Q34128351 | Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells |
| Q33900859 | Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol |
| Q37243917 | Biological functions and metabolism of oleoylethanolamide |
| Q33720127 | Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators |
| Q35166600 | Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases |
| Q44504754 | Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure |
| Q37624013 | Brain region-specific changes in N-acylethanolamine contents with time of day. |
| Q36749082 | Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system |
| Q34239091 | Cannabinoid hyperemesis syndrome |
| Q34245609 | Cannabinoid receptor 1 signaling in embryo neurodevelopment |
| Q52027564 | Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus. |
| Q48506995 | Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. |
| Q35594830 | Cannabinoid receptors and endocannabinoids: evidence for new players. |
| Q41753811 | Cannabinoid receptors and their endogenous agonist, anandamide |
| Q35897353 | Cannabinoid signaling in glial cells |
| Q55506613 | Cannabinoids and Reproduction: A Lasting and Intriguing History. |
| Q34520143 | Cannabinoids and neuroprotection |
| Q37264965 | Cannabinoids as therapeutic agents for ablating neuroinflammatory disease |
| Q34549222 | Cannabis and cannabinoid receptors: from pathophysiology to therapeutic options |
| Q48405803 | Cannabis and endogenous cannabinoid systems. |
| Q35035836 | Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges |
| Q88600929 | Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling |
| Q34749934 | Control of pain initiation by endogenous cannabinoids. |
| Q35924804 | Critical enzymes involved in endocannabinoid metabolism |
| Q36439202 | Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide |
| Q46764070 | Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. |
| Q64248632 | Diurnal Profiles of -Acylethanolamines in Goldfish Brain and Gastrointestinal Tract: Possible Role of Feeding |
| Q41646203 | Dopamine activation of endogenous cannabinoid signaling in dorsal striatum |
| Q36184904 | Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse |
| Q33865224 | Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices |
| Q46163967 | Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. |
| Q92097847 | Endocannabinoid System and Alcohol Abuse Disorders |
| Q26823256 | Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways |
| Q35754490 | Endocannabinoid signalling and the deteriorating brain |
| Q30391852 | Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration |
| Q55282369 | Endocannabinoids |
| Q35025270 | Endocannabinoids and their actions |
| Q33757950 | Endocannabinoids in the dentate gyrus |
| Q41742759 | Endocannabinoids: a new class of vasoactive substances |
| Q48309971 | Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action |
| Q33899850 | Endogenous cannabinoid signaling and psychomotor disorders |
| Q43574291 | Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals |
| Q34018061 | Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality |
| Q37568597 | Enzymatic formation of anandamide |
| Q39831177 | Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. |
| Q28390932 | Enzymatic pathways that regulate endocannabinoid signaling in the nervous system |
| Q74258295 | Enzymology of cottonseed microsomal N-acylphosphatidylethanolamine synthase: kinetic properties and mechanism-based inactivation |
| Q27325738 | Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain |
| Q44793025 | Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function |
| Q36916109 | Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism. |
| Q37785382 | Fatty acid amide signaling molecules |
| Q26777055 | Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling |
| Q48171307 | Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response |
| Q35575013 | Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine |
| Q34786818 | From cannabis to cannabinergics: new therapeutic opportunities |
| Q34332678 | Functional disassociation of the central and peripheral fatty acid amide signaling systems |
| Q36234744 | Generation of N-acylphosphatidylethanolamine by members of the phospholipase A/acyltransferase (PLA/AT) family |
| Q28284073 | Identification of a high-affinity binding site involved in the transport of endocannabinoids |
| Q90372053 | Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses |
| Q35752224 | Involvement of cannabinoid receptors in gut motility and visceral perception |
| Q48513242 | Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. |
| Q37295577 | Lipidomic analysis of endocannabinoid metabolism in biological samples. |
| Q42156441 | Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines |
| Q43649052 | Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations |
| Q24680869 | Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes |
| Q39370805 | Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years |
| Q36477987 | Microglia produce and hydrolyze palmitoylethanolamide |
| Q36748119 | Modulation of fear and anxiety by the endogenous cannabinoid system |
| Q34191266 | Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. |
| Q37373721 | More surprises lying ahead. The endocannabinoids keep us guessing |
| Q34098995 | N-Acylethanolamines and precursor phospholipids - relation to cell injury |
| Q24555159 | N-Acylethanolamines in seeds. Quantification Of molecular species and their degradation upon imbibition |
| Q73263801 | N-Acylethanolamines in signal transduction of elicitor perception. Attenuation Of alkalinization response and activation of defense gene expression |
| Q30493991 | Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. |
| Q90341504 | Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers |
| Q61449859 | Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse |
| Q37568602 | Organized trafficking of anandamide and related lipids |
| Q42665834 | PPAR-alpha in cutaneous inflammation |
| Q42580206 | Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease |
| Q28390536 | Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide |
| Q40639597 | Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. |
| Q35381177 | Palmitoylethanolamide inhibits glutamate release in rat cerebrocortical nerve terminals |
| Q34098970 | Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? |
| Q38287127 | Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain |
| Q34642573 | Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons |
| Q35222716 | Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context |
| Q36476735 | Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier |
| Q34647336 | Phosphatidylserine in the brain: metabolism and function |
| Q43715218 | Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors |
| Q34247119 | Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides |
| Q35310789 | Putative N-acylphosphatidylethanolamine synthase from Arabidopsis thaliana is a lysoglycerophospholipid acyltransferase |
| Q34786823 | Putative neuroprotective actions of N-acyl-ethanolamines |
| Q37105737 | Quantitative analysis of N-acylphosphatidylethanolamine molecular species in rat brain using solid-phase extraction combined with reversed-phase chromatography and tandem mass spectrometry |
| Q40387198 | Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain |
| Q43570212 | Receptor-dependent formation of endogenous cannabinoids in cortical neurons |
| Q42791197 | Regulation of brain anandamide by acute administration of ethanol |
| Q36726650 | Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes |
| Q35600288 | Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. |
| Q43962847 | Substantial species differences in relation to formation and degradation of N-acyl-ethanolamine phospholipids in heart tissue: an enzyme activity study |
| Q38041843 | Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function |
| Q90405275 | Synopsis of arachidonic acid metabolism: A review |
| Q37553151 | Targeted lipidomics as a tool to investigate endocannabinoid function. |
| Q38659944 | The Endocannabinoid Signaling System in the CNS: A Primer. |
| Q42110966 | The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons |
| Q34305854 | The endocannabinoid nervous system: unique opportunities for therapeutic intervention |
| Q35989527 | The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism. |
| Q35876026 | The endocannabinoid system and its therapeutic exploitation |
| Q34098196 | The endocannabinoid system as a target for the treatment of neurodegenerative disease |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q35639524 | The endocannabinoid system: a general view and latest additions |
| Q35035840 | The enzymatic inactivation of the fatty acid amide class of signaling lipids |
| Q46345584 | The major glycerophospholipids of the predatory and parasitic bacterium Bdellovibrio bacteriovorus HID5. |
| Q29615356 | The molecular logic of endocannabinoid signalling |
| Q24522320 | The neurobiology and evolution of cannabinoid signalling |
| Q33906007 | Towards cannabinoid drugs--revisited. |
| Q34400095 | Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia |
| Q30988581 | Two unusual glycerophospholipids from a filamentous fungus, Absidia corymbifera |
| Q35069599 | Voluntary running in young adult mice reduces anxiety-like behavior and increases the accumulation of bioactive lipids in the cerebral cortex |
| Q33664684 | Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis |
| Q24313273 | cDNA cloning and characterization of human and mouse Ca(2+)-independent phosphatidylethanolamine N-acyltransferases |
Search more.